Judge To Keep J&J CEO Off Stand In Risperdal Case
A Pennsylvania state judge said Monday that he won't reconsider his order quashing testimony from Johnson & Johnson's CEO as part of litigation accusing a J&J subsidiary of marketing antipsychotic drug...To view the full article, register now.
Already a subscriber? Click here to view full article